NCT07476248Not yet recruiting
The Non-high-density Lipoprotein Cholesterol (Non-HDL-C) to High-density Lipoprotein Cholesterol (HDL-C) Ratio (NHHR) and Its Association With Occurrence of Diabetic Nephropathy in Patients With Diabetes Mellitus
Source: ClinicalTrials.gov · Last updated 17 Mar 2026
Brief summary (registry, in English)
The study aims to examine the relationship between the non-high-density lipoprotein cholesterol-to-high-density lipoprotein cholesterol ratio (NHHR) and CKD in patients with DM.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 84 (estimated)
- First submitted
- 12 Mar 2026
- Start date
- Oct 2026
- Primary completion date
- Oct 2027
- Lead sponsor
- Assiut University
- NCT number
- NCT07476248
What you commit to
- Study type: Observational
- Planned participants: 84
- From Oct 2026 to the primary completion date, Oct 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Current use of medications known to significantly alter lipid metabolism (other than standard lipid-lowering therapy, if applicable)
Other illness
- Known non-diabetic causes of chronic kidney disease
- Chronic inflammatory or autoimmune diseases
- End-stage renal disease patients on dialysis
Other
- Acute kidney injury
Who the study is looking for
- Adults aged ≥18 years
- Diagnosed cases of diabetes mellitus (Type 1 or Type 2), with or without diabetic nephropathy
- Willingness to participate and provide informed consent
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.